treatment of T-cell lymphoma
All entries for: Evopoint Biosciences USA Inc.
April 13, 2026
Evopoint Biosciences USA Inc.
Orphan Drug Designation
Disease Area: Rare Diseases
treatment of T-cell lymphoma